Le Lézard
Classified in: Ebola virus, Health
Subject: MRR

Incontinence Care Products (ICP) Market worth $16.5 billion | MarketsandMarkets


CHICAGO, Sept. 20, 2023 /PRNewswire/ -- The Incontinence Care Products (ICP) market has experienced significant growth in recent years, driven by an aging population, increased awareness about urinary and fecal incontinence issues, and advancements in product innovation. This market encompasses a wide range of products, including adult diapers, disposable underpads, urinary catheters, and skin care solutions. As healthcare systems strive to improve patient comfort and reduce the risk of infections, the demand for high-quality ICPs continues to rise. Additionally, sustainability concerns have led to the development of eco-friendly and biodegradable options within this market. With the ICP market poised for continued expansion, manufacturers are focusing on enhancing product performance, comfort, and environmental sustainability to meet the evolving needs of both healthcare institutions and individuals seeking effective incontinence care solutions.

MarketsandMarkets_Logo

Incontinence Care Products (ICP) Market in terms of revenue was estimated to be worth $12.6 billion in 2023 and is poised to reach $16.5 billion by 2028, growing at a CAGR of 5.6% from 2023 to 2028 according to a new report by MarketsandMarketstm. Growth in the incontinence care products market is mainly driven by the increasing geriatric population and subsequent rise in the prevalence of chronic medical conditions, significant prevalence of incontinence, growing attention to personal hygiene. Rapid urbanization and rising disposable income also contribute to the growth of the market. In addition, emerging markets such as India and China are expected to offer growth opportunities for players operating in the incontinence care products market during the forecast period. However, disparities in the reimbursement for incontinence care products is restricting the growth of this market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=71950351

Browse in-depth TOC on "Incontinence Care Products (ICP) Market"

209 - Tables
44 - Figures
225 - Pages

Incontinence Care Products (ICP) Market Scope:

Report Coverage

Details

Market Revenue in 2023

$12.6 billion

Estimated Value by 2028

$16.5 billion

Growth Rate

Poised to grow at a CAGR of 5.6%

Market Size Available for

2021?2028

Forecast Period

2023?2028

Forecast Units

Value (USD Billion)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Segments Covered

Product Type, Gender, Usage, Distribution Channel, and End user

Geographies Covered

North America, Europe, Asia Pacific, and Rest of the World

Report Highlights

Updated financial information / product portfolio of players

Key Market Opportunities

Rising adoption of smart diapers

Key Market Drivers

Increasing geriatric population with chronic medical conditions

In 2022, the absorbable segment held the largest share of the incontinence care products market, by product type segment

Based on product type, the global incontinence care products market is categorized into absorbents and non-absorbents. Absorbents provide better comfort to incontinence patients by preventing the leakage of urine, making it a preferred option, hence accounting for large share. These products are also easy to use as compared to non-absorbents.

In 2022, the e-commerce segment held the largest share of the incontinence care products market, by distribution channel segment

By distribution channel, the incontinence care products market has been segmented into e-commerce, retailer pharmacies, and hospital pharmacies. The large share of this segment can be attributed to factors such as increasing digitalization, advancements in technology, and rising internet accessibility. Besides, the products sold on e-commerce platforms are comparatively more affordable than the products sold offline, since the costs associated with warehouse storage and maintenance is not involved.

Europe dominates the global incontinence care products market

Based on the region, the incontinence care products market is segmented into North America, Europe, Asia Pacific, and Rest of the world. In 2022, Europe accounted for the largest incontinence care products market share. The large share of Europe in this market can be attributed to the increasing prevalence of incontinence and chronic conditions and rising healthcare spending. In addition, various key players have their headquarters or major sales networks situated in European countries, making it a mature and developed market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=71950351

Incontinence Care Products (ICP) Market Dynamics:

Drivers:

  1. Increasing geriatric population with chronic medical conditions
  2. Significant prevalence of incontinence
  3. Growing attention to personal hygiene
  4. Rapid urbanization and rising disposable income

Restraints:

  1. Social stigma associated with incontinence care products
  2. Environmental concerns related to disposal of incontinence products

Opportunities:

  1. Development of bio-based superabsorbent polymers
  2. Rising adoption of smart diapers

Challenge:

  1. Underreporting of fecal incontinence
  2. Disparities in reimbursement for incontinence care products

Key Market Players:

The major players operating in this market are Essity Aktiebolag (publ) (Sweden), Kimberly-Clark Corporation (US), The Procter & Gamble Company (US), HARTMANN (Germany), Ontex BV (Belgium), Unicharm Corporation (Japan), Coloplast A/S (Denmark), Cardinal Health, Inc. (US), Medline Industries, LP (US), McKesson Corporation (US), ABENA (Denmark), Attindas Hygiene Partners Group (US), Hollister Incorporated (US), Dynarex Corporation (US), ConvaTec Group Plc (UK), Becton, Dickinson, and Company (US), Wellspect Healthcare (Sweden), Stryker (US), First Quality Enterprises, Inc. (US), Principle Business Enterprises, Inc. (US), TZMO SA (Poland), Primare International Ltd. (Canada), Drylock Technologies (Belgium), NorthShore Care Supply (US), and Nobel Hygiene (India).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=71950351

Incontinence Care Products (ICP) Market Advantages:

Overall, the Incontinence Care Products market plays a crucial role in enhancing the well-being and independence of individuals dealing with incontinence issues while offering a range of benefits to society and the economy.

Related Reports:

Microcatheters Market - Global Forecasts to 2028

Neurovascular Devices Market - Global Forecasts to 2028

Medical Supplies Market - Global Forecasts to 2027

Electrophysiology Market - Global Forecasts to 2027

ERCP Market - Global Forecasts to 2026

About MarketsandMarketstm:

MarketsandMarketstm is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStoretm (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarketstm.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarketstm INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/incontinence-care-products-ipc-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/incontinence-care-products-ipc.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg


These press releases may also interest you

at 17:25
Talphera, Inc. , ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that the Board of Directors of Talphera has granted...

at 16:56
A paper published in the June edition of the Journal Diabetes demonstrates that C-peptide, a biomarker that indicates the production of insulin, is a validated surrogate endpoint, or predictor of clinical benefit, for clinical trials of...

at 16:28
?Patients Treated with ARIKAYCE Plus Macrolide-Based Background Regimen Had Meaningfully Greater Improvements in Respiratory Symptoms vs. Macrolide-Based Background Regimen Alone, As Measured By the QOL-B Respiratory Domain Instrument? ?QOL-B...

at 16:20
Jarrard Inc., a leading national healthcare strategic communications consultancy, has expanded by 10 percent, adding seven new professionals to address the increasing demand for its healthcare advisory services. The team now includes 81 full-time...

at 16:10
Pulse Biosciences, Inc. ("Pulse" or the "Company"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that the Company's Board of Directors has determined a new record...

at 16:10
Contineum Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of...



News published on and distributed by: